UK reward metrics · Health & Protection

Do UK organisations fund private diagnostics or fast-track cancer pathways (beyond core PMI)?

Source lumi HRBase 265 organisationsFieldwork 2026 H1

77.4%No

77.4% of organisations in the lumi HR community answered “No” on private cancer diagnostics and fast-track pathways (base: 265 UK organisations, 2026 H1).

Figures describe organisations in the lumi HR community, not a random sample of UK employers.

How UK organisations answered

Yes dedicated pathway 15.1% Via PMI 7.5% No 77.4%
Private cancer diagnostics and fast-track pathways (base: 265 organisations, 2026 H1). Percentages percentages may not sum to 100 because of rounding.
Private cancer diagnostics and fast-track pathways: share of organisations by answer
AnswerShare of organisations
Yes dedicated pathwayrare15.1%
Via PMIrare7.5%
Nocommon77.4%

Common, alternative and rare describe how each answer sits against the community: the most chosen answer is common; an answer chosen by fewer than one in five organisations is rare.

Definition

Captures whether private cancer diagnostics or fast-track pathways are funded as a dedicated benefit, via PMI, or not at all. See the methodology for how the base is built, how not-applicable answers are handled, the public floor, and which organisations are excluded.

Cite this figure
Source: lumi HR, UK Reward Metrics, September 2026, lumihr.co.uk/metrics/private-cancer-diagnostics-and-fast-track-pathways
Last updated 19 September 2026 · Data licence: CC BY 4.0 for the figures in the CSV download.

See how your organisation compares

Members see their own organisation against the peer group, by sector and size, on every metric.

Book a call